Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial Infection: A Case Report and Review of the Literature.

PURPOSE

Intracranial infection after neurosurgery is one of the most serious complications, especially extensively drug-resistant (XDR) () seriously affects the prognosis of patients. At present, there is little experience in the treatment of this infection and limited effective treatment options, like tigecycline or polymyxin B. Therefore, this report aims to describe the efficacy of tigecycline combined with polymyxin B by intrathecal (ITH) injection in the treatment of XDR intracranial infection with .

METHODS

We report a case of intracranial infection with XDR after ventricular drainage, treated by daily ITH and intravenous (IV) tigecycline, combined with polymyxin B ITH route. Moreover, tigecycline and polymyxin B treatments for XDR intracranial infection with that were reported in the literature were also reviewed and summarized.

RESULTS

The white blood cells (WBCs) of the patient's cerebrospinal fluid dropped to normal, and the symptoms of intracranial infection disappeared. The patient finally obtained good clinical results and transferred to the local hospital.

CONCLUSION

The polymyxin B ITH route is an ideal treatment strategy for XDR . The IV plus ITH tigecycline may be an effective treatment option. However, more researches should be conducted to confirm our observation.